Professional Documents
Culture Documents
Cellular Mechanisms in Sympatho-Modulation of The
Cellular Mechanisms in Sympatho-Modulation of The
net/publication/8559981
CITATIONS READS
28 1,161
2 authors, including:
Marcus Schaub
University of Zurich
174 PUBLICATIONS 5,591 CITATIONS
SEE PROFILE
All content following this page was uploaded by Marcus Schaub on 05 June 2014.
Heart function, in terms of contractile force (inotropy), molecular characteristics pertain to the human protein
beating frequency (heart rate) and blood supply (vascular species. Clinical aspects of the individual sympatho-
tone), relies on a three-tiered control system: (i) immediate modulatory therapies in perioperative medicine, based on
and fast feedback responses of the cardiac tissue to the these new experimental ®ndings, will be presented in the
actual mechanical load; (ii) regulation of cardiac perform- article `Sympatho-modulatory therapies in perioperative
ance by the autonomous nervous system involving humoral medicine' by Zaugg and Schaub in this issue.
primary messengers affecting the intracellular signalling
systems; and (iii) long-term adaptation to altered
physiological and pathological conditions produced by Adrenergic receptor subtype-speci®c
changes in gene expression. The ®rst two modes of
signalling via G-proteins
regulation are partially overlapping and primarily depend
on the sympathetic nervous system. Repetitive peak Acute and long-term regulation of myocardial function,
responses, as they occur perioperatively, are part of the including heart rate, systolic and diastolic function and
life-supporting adrenergic drive, which, however, may turn metabolism, are primarily governed by the b1- and b2-
into potentially life-threatening maladaptation. Gaining adrenergic receptor (AR) signalling pathways. A functional
control over sympathetic nervous system activity by blunt- role for the a-AR is less well established, although positive
ing the adrenergic responses to the surgical trauma and and negative inotropic effects have been attributed to
perioperative stress is an important task in anaesthetic speci®c a-AR subtypes, particularly in cardiomyopathies
practice. The present review summarizes substantially new and heart failure.11 24 43 54 69 72 76 The human AR
experimental results on adrenergic cellular and molecular superfamily consists of nine subtypes originating from
mechanisms. Because of limitations of space, reviews will different genes (with single polypeptide chains varying in
often be cited where further references to the primary length from 408 to 572 amino acid residues): a1A, a1B, a1D,
literature can be found. Unless otherwise stated, the a2A, a2B, a2C, b1, b2 and b3. All these cell surface receptors
Ó The Board of Management and Trustees of the British Journal of Anaesthesia 2004
Mechanisms in sympatho-modulation
contain an extracellular N-terminus, seven transmembrane ways are interconnected and form a robust network with
a-helices (TM1±TM7) and an intracellular C-terminal ample redundancy. This complexity allows subtle modula-
region. They are all able to couple to the guanine tion of individual cellular responses.
nucleotide-binding G-proteins and are therefore called G- The GPCRs constitute the third-largest family of genes
protein-coupled receptors (GPCRs). The extracellular present in the human genome, and represent a central target
N-terminal region, together with the extracellular loops structure for drug development. However, their therapeutic
between the TM2 and TM7 helices, contributes to the use is often limited by unwanted side-effects. Some of these
formation of the extracellular ligand binding pocket, derive from the binding of the drugs to related receptor
whereas the amino acid sequences of the intracellular subtypes.11 72 74 76 90 In the normal human myocardium, b1-
domains (loops) between the TMs, together with the AR is the most abundant species (70±80%), a1 and b2
proximal portion of the C-terminal region, are involved in account for over 10% each, and b3 is low (around 1%).
mediating G-protein coupling. Activated G-proteins trans- However, heart failure caused by either dilated or ischaemic
mit signals to speci®c intracellular targets (Fig. 1). The cardiomyopathy is accompanied by selective down-regula-
downstream signalling pathways involve sequential protein tion of b1-AR, entailing a relative increase in both a1A and
phosphorylation cascades that ultimately affect targets in b2, which together amount to ~50% of total ARs. In the
the cytoplasm or operate via transcriptional factors affecting failing heart, the b3-AR protein concentration increases by a
gene expression. A second group of enzymes, the protein factor of 3.
phosphatases, are responsible for dephosphorylation and ARs couple to the heterotrimeric G-protein complex (Ga,
termination of signalling. All intracellular signalling path- Gb, Gg) on the inner side of the cell membrane.3 12 60 76 94
35
Zaugg and Schaub
Upon activation, the Ga-subunit hydrolyses guanosine (Fig. 1). The b1-AR couples almost exclusively to Gas,
triphosphate (GTP) and dissociates from the complex, inducing positive inotropy (increased contractile amplitude)
leaving the bg-subunits as undissociable heterodimer and positive lusitropy (enhanced relaxation). Its canonical
(Fig. 1). Currently there are 20 known Ga, six Gb and signalling pathways involve activation of AC and protein
eleven Gg subunits. When activated, all three a1-ARs kinase A (PKA). b2- and b3-ARs are both able to signal via
interact with the pertussis toxin-insensitive Gaq component, Gas, Gai or Gaq depending on the physiological or
which follows the main signalling route via phospholipase C pathophysiological conditions (different states with regard
(PLC) leading to diacylglycerol (DAG), producing activ- to catecholamines, in¯ammatory cytokines and angiotensin-
ation of protein kinase C (PKC) and inositol trisphosphate II). The Gas and Gaq protein families have de®ned main
(IP3) for the liberation of Ca2+ from the sarcoplasmic effector pathways: the AC and the PLC pathways, respect-
reticulum (SR). All three a2-ARs couple to the pertussis ively. The Gai protein family is more amorphous and its
toxin-sensitive Gai, leading to inhibition of the integral signalling ¯ows equally through both the Gai and the Gbg
membrane protein adenylyl cyclase (AC), activation of K+- complex, affecting several different downstream signalling
channels, and inhibition of the sarcolemmal L-type Ca2+ pathways. Gaq-dependent signalling by the heterodimeric
entry channels (DHPR). This is in contrast to the b-ARs, Gbg to the phosphoinositol-3 kinase (PI3K) pathway was
which are more variable in their coupling to G-proteins recently established in cardiac hypertrophy.20
36
Mechanisms in sympatho-modulation
AC is an integral membrane protein with 12 transmem- transglutaminase-II.29 All three types are expressed in
brane helices and a molecular weight of ~130 kDa.25 26 65 At cardiomyocytes.
least nine isoforms of the AC exist (AC1±AC9); AC5 is
speci®cally expressed in cardiomyocytes, whereas AC6
occurs in heart cells other than myocytes. Additional Regulation of adrenergic receptor signalling
isoforms are also expressed in the heart, but to a lesser The b2-AR is the most thoroughly studied with regard to
degree. In addition to its regulation by G-proteins signalling. Four paradigms have been delineated from
(stimulatory Gas and inhibitory Gai), PKC further stimu- studies of co-expression of wild-type and mutated b2-AR
lates and PKA inhibits the activity of AC isoforms. with various combinations of G-proteins in different in vitro
Furthermore, high Ca2+ during sustained cell activity cell systems. One assumes that these regulatory mechanisms
inhibits AC5 and AC6, establishing a negative feedback also apply to the other GPCRs in different tissues.
loop. The ®ne tuning in the regulation of AC is of particular (i) Upon agonist activation, the b2-AR couples to the G-
signi®cance as its activity is rate-limiting in adrenergic protein heterotrimer, mainly with its third intracellular loop
signal transmission. PLC is a peripheral membrane protein between the transmembrane helices TM5 and TM6 and part
at the cytoplasmic side, hydrolysing phosphatidylinositol of the intracellular C-terminus immediately following the
4,5-bisphosphate (PIP2) to DAG and IP3 (Figs 2 and 3). It TM6. It couples preferentially to Gas forming a stoichio-
has an absolute requirement for Ca2+ bound to the active site metric 1:1 complex. However, the b2-AR may instead also
and comprises three types: PLCb (150 kDa), stimulated by couple to Gai or Gaq, activating their corresponding
G-proteins; PLCg (150 kDa), stimulated by receptor signalling pathways (Fig. 1). The G-protein speci®city is, at
tyrosine kinases; and PLCd (84 kDa), stimulated by least in part, determined by the type of agonist.94 This
37
Zaugg and Schaub
implies that the agonist-induced conformation of the plex AP2, delivers the receptor to clathrin-coated pits for
receptor favours the type of G-protein with which it endocytosis to endosomes or to lysosomes. In the endo-
interacts. For instance, salbutamol and ephedrine display a somes the b2-AR is dephosphorylated by speci®c protein
much higher ef®cacy with Gaq than Gas or Gai. On the phosphatases. This resensitized receptor then recycles back
other hand, isoproterenol is more effective than salbutamol to the cell membrane. However, fusion of the endosome
with Gai. It was recently shown that the selective b2-AR with lysosomes leads to b2-AR degradation. Desensitization
antagonist ICI-118,551 exerts a direct negative inotropic is not always coupled to internalization but exhibits receptor
effect by acting as a b2-AR agonist, directing it away from type-speci®city. For instance, under agonist stimulation
coupling to Gas towards coupling to Gai.28 Furthermore, 50±80% of the b2-AR internalizes within a few minutes,
upon stimulation by catecholamines the b2-AR interacts whereas the b1-AR does not internalize but remains at the
much faster with Gas than with Gai and Gaq. This could cell surface, even in the desensitized state. The different
generate intracellular signals in a timely, ordered fashion. In a-ARs internalize only moderately, except for the a2A-AR,
general, AR signalling is terminated by phosphorylation at which remains at the membrane. In contrast to desensitiza-
multiple sites in the third intracellular loop and in the tion, downregulation denotes a chronic process, during
C-terminal region. However, PKA-dependent phosphoryl- which agonist overstimulation promotes increased receptor
ation in the third loop (serines 261 and 262) and in the degradation concomitant with a reduced de novo synthesis
proximal C-terminal region (serines 345 and 346) of the rate that does not match the loss of receptors.12 71
b2-AR switches its predominant coupling from the stimu- (iii) Recent reports on homo- and heterodimerization
latory Gas to the inhibitory Gai, thereby inhibiting the AC between receptor subtypes suggest a potential concentration
and promoting activation of the mitogen activated protein of receptor complexity that could account for previously
38
Mechanisms in sympatho-modulation
PKA and PKC are the key players in the adrenergic signal lasting cytoplasmic increase in Ca2+ concentration activat-
relay system. In the absence of cAMP, PKA is an ing metabolism as well as gene expression, or short-lasting
enzymatically inactive tetrameric holoenzyme consisting (50±200 ms) Ca2+ transients triggering contraction.7 8 14
of two catalytic subunits (PKAC monomer, 40.4 kDa) Calcium signalling for different cellular responses and its
bound to a regulatory subunit dimer (PKAR monomer, 42.5 consequent requirement for energy production depend on
kDa). cAMP binds cooperatively to two sites on each PKAR the strictly maintained intracellular Ca2+ homeostasis,
subunit. Upon binding of four molecules of cAMP, the which is largely monitored by adrenergic signalling path-
enzyme dissociates into a PKAR dimer with four molecules ways (Fig. 3). The heart makes up less than 0.5% of the
of cAMP bound, and two free, active PKACs. The PKC body mass, yet it consumes around 11% of the total energy
exists in a variety of isoforms with functional speci®cities. expenditure. The complex scheme in Fig. 3 comprises the
There are 10 mammalian PKC isoforms, ranging in explicitly reported interconnections between the intra-
molecular weight from 68 to 102 kDa. The four conven- cellular adrenergic and Ca2+ signalling pathways, but in
tional PKCs (a, b1 with a splice variant b2, and g) require reality probably many more may exist. In the resting
Ca2+ and DAG for activation; the four novel PKCs (d, e, h/L myocyte the cytoplasmic Ca2+ concentration is below 10±7
and q) are Ca2+-independent but require DAG for acti- M and increases transiently by almost two orders of
vation; ®nally, the two atypical PKCs (z and l) lack both the magnitude upon stimulation by the action potential (AP).
Ca2+ and the DAG binding domain. The Ca2+ concentration in the mitochondrial matrix follows
G-proteins are also able to activate the monomeric closely that of the cytoplasm, involving the regulation of
GTPase Ras via different phosphorelay systems. Ras metabolic key enzymes of the tricarboxylic acid cycle.14 99
represents a master switch in transferring extracellular Several ATP-consuming ion pumps and electrogenically
39
Zaugg and Schaub
L- and T-type channels belong to a family of cell surface cin (sirolimus), but not by cyclosporin A. Of the three
Ca2+-channels composed of four subunits in a 1:1 isoforms, RYR1 (with a total molecular weight of around
stoichiometry (a1, a2, b, d). The human a1C (Cav1.2) 2300 kDa) occurs in skeletal muscle, RYR2 in cardiomyo-
subunit (2221 amino acids, 249 kDa), occurring in heart cytes and RYR3 in non-muscle cells.49 88 In addition, the
(Cav1.2a) and smooth muscle (Cav1.2b sharing 93% RYR2 serves as scaffold protein, combining with numerous
homology), contains four domains with six transmembrane key regulatory components in the junctional SR complex,
helices each (S1±S6, yielding a total of 12 transmembrane including CaM, PKA, type-1 and type-2 phosphatases and,
helices). The S6s of each domain together form the Ca2+ at the luminal SR surface, triadin and calsequestrin.
pore. The four transmembrane S4 helices of 19 amino acids Calcium can also be released from the SR via the IP3R
each contain positively charged residues at every third channel, which is composed of four equal subunits of 313
position, together forming the voltage sensor of the pore. kDa each. The IP3R channel also exists in three isoforms,
The P-loop between the transmembrane helices S5 and S6 is with IP3R2 in cardiomyocytes. The IP3R2 is activated by
very much conserved among the different Ca2+-channels IP3 produced by PLC. The rate and extent of Ca2+ liberation
and provides the ®lter selectivity for Ca2+. The b-subunit by IP3 is much lower than for CICR via the RYR2, and thus
associates with the a-subunit at the inner side of the hardly contributes to excitation±contraction coupling in
membrane and determines the kinetics of the channel cardiomyocytes. However, intracellular Ca2+ release by IP3
activities (opening, closing, inactivation). The b2-subunit is important in the slow motion of smooth muscle contrac-
(73.5 kDa) is characteristic of the heart while the b3-subunit tion and in ®ne-tuning the activity of atrial myocytes, where
(54.5 kDa) is more typical of smooth muscle. The Cav1.2 the SR has more IP3R2 than in the ventricular myocytes.
channel activity is enhanced by phosphorylation by PKA, RYR2 and IP3R2 share structural and functional similarities
40
Mechanisms in sympatho-modulation
3). In mice and rats, about 92% of the Ca2+ ions are pumped important component linking adrenergic control to inotropy
back into the SR by the SERCA2a and only 7% are extruded and rhythmicity.4 8 14 22 48 Three genes were identi®ed for
out of the cell by the NCX1. In larger mammals, such as the SR Ca2+ pump, SERCA1, SERCA2 and SERCA3,
rabbits, cats, dogs and humans, SERCA2a and NCX1 are which are spliced into several isoforms. SERCA1a is mainly
able to lower the Ca2+ concentration to about 70 and 28% expressed in fast skeletal muscle, while SERCA1b is
respectively. The slow sarcolemmal PMCA pump con- abundant in fetal and neonatal tissues. The SERCA2 gene
tributes little (1±2%) to the process of lowering the encodes four splice variants: SERCA2a, expressed in the
cytoplasmic Ca2+ concentrations in the heart, whereas its heart and in slow skeletal muscle, SERCA2b, expressed in
function is decisive for Ca2+ homeostasis in smooth and smooth muscle and with variants (types 2 and 3) in non-
non-muscle cells. muscle cells and (type 4) in neuronal cells. The recently
The amount of AP-induced Ca2+ entry is primarily solved crystal structure of the SERCA1a pump in the Ca2+-
dictated by the duration of the AP and the open probability bound state reveals (besides the 10 transmembrane helices)
of the L-type Ca2+-channel. The Ca2+ extruded after the three large cytoplasmic domain structures constituting the
heart-beat must match the amount of Ca2+ that enters just nucleotide binding site, the catalytic site and the phos-
before the beat, otherwise the cell would not be in phorylation site.91 The cardiac SERCA2a is 997 amino
steady state but would either lose or gain Ca2+. This acids long (110 kDa) and is under the direct control of a
provides a quantitative framework for the dynamic Ca2+ CaM-dependent kinase-II (CaMK-II), which enhances its
¯uxes in the cardiomyocytes. The SERCA2a pump is one of transport capacity by phosphorylation of Ser38. The major
the main players in terminating contraction and restoring regulator of SERCA2a, however, is PLN, with 52 amino
resting cytoplasmic Ca2+ concentrations. It is known that
41
Zaugg and Schaub
42
Mechanisms in sympatho-modulation
Frank±Starling and negative feedback induced Ca2+ release from the SR via the RYR2, thus also
mechanisms acting as a second messenger. Furthermore, the second
messenger IP3, liberated by PLC from PIP2 (as mentioned
Physiological contraction generates both isometric force
above), provokes the release of Ca2+ via the IP3R of the SR,
(ventricular pressure) and rapid shortening to eject the acting then as a third messenger. In addition, adrenergic
blood. As discussed above, there are two main ways to signalling pathways exert their effects (balancing between
change the strength of contraction: by altering the amplitude positive or negative inotropy and lusitropy) almost exclu-
and/or duration of the Ca2+ transient, and by altering the sively by modulating cytoplasmic Ca2+ concentrations and
sensitivity of the contractile ®laments to Ca2+ (by phos- signalling transients in amplitude and frequency, thus
phorylation of the myosin RLC and/or TnI). Calcium- adding yet another step to the Ca2+ signalling cascade.
sensitivity also increases by mechanical stretching as the Consequently, Ca2+ may well be viewed as operating at the
heart ®lls with blood, resulting in stronger subsequent same time as a ®rst, second and third messenger. In the
contraction.23 This is due to the compression of the healthy heart, the combined signalling circuits coordinate
transverse ®lament lattice that occurs on stretching and contractility and energy production in a concerted way. The
brings the contractile ®laments in the sarcomeres closer cellular and molecular basis explains how adrenergic
together. This facilitates actin±myosin interaction and stimulation induces positive inotropy together with positive
increases the af®nity of TnC for Ca2+. It represents an lusitropy (faster relaxation) under increased haemodynamic
important autoregulatory mechanism by which the heart load. This combination of stronger but shorter contraction
adjusts to increased diastolic ®lling, and is called the Frank± twitches makes it possible to accommodate more beats per
Starling response. time interval, thus increasing cardiac output under increased
43
Zaugg and Schaub
44
Mechanisms in sympatho-modulation
second with 210 kDa, and the third consisting of only the Dephosphorylation of MBS proceeds slowly and does not
C-terminal immunoglobulin-like domain of 17.5 kDa allow fast relaxation of the contractile apparatus.
(lacking the catalytic and regulatory domains), called However, another small molecular weight (16.7 kDa)
telokin. The short species (130 kDa) predominates in protein, CPI-17, is a potent reversible inhibitor of
smooth muscle while the long isoform (210 kDa) occurs MLCP.84 86 The inhibitory activity of CPI-17 is increased
in many different non-muscle tissues and to a lesser extent more than 1000-fold by phosphorylation at Ser38 by PKC,
also in smooth muscle cells. Telokin is mainly found in PKA, PKG or ROK, and also quickly reversed upon
phasic smooth muscle tissues and may contribute to Ca2+ dephosphorylation by the protein serine±threonine phos-
desensitization by cyclic nucleotides. The MLCK isoforms phatases PP2A, PP2B and PP2C, but not by type-1 protein
of smooth and non-muscle tissues contain in their phosphatases. Consequently, CPI-17 is considered to act in
N-terminal region several immunoglobulin-like domains, concert with myosin RLC phosphorylation by MLCK as the
one ®bronectin-like domain, and an actin-binding sequence, on±off switch of smooth muscle contraction.
all of which are not present in the skeletal muscle MLCK.
When Ca2+ binds to CaM, it associates with MLCK,
Phasic contraction and vascular tone
resulting in its activation and phosphorylation of the RLC
(Fig. 5). At this point, catecholamine signalling via b2-AR The Rho±ROK signalling pathway represents a sophisti-
is connected to the activation process of smooth muscle cated device for ®ne-tuning vascular tone subject to a
contraction, allowing relaxation even in the presence of variety of agonists, including noradrenaline, angiotensin-II,
activatory Ca2+ concentrations. Phosphorylation of MLCK endothelin, vasopressin, thrombin, prostanoids and many
others.75 84 86 89 95 All these agonists operate via Gaq-
45
Zaugg and Schaub
ROK-II is also able to phosphorylate the myosin RLC and newer experimental evidence rejects this possibility.
thus contributes in two ways to the maintenance of vascular Interestingly, most of the L-type Ca2+-channels are found
tone. in surface membrane caveolae closely packed together with
Another mechanism contributing to the vascular tone is the Na+±Ca2+-exchanger (NCX1), the Na+±K+ pump, the
the integrin-linked kinase system (Fig. 5).36 89 Integrins are sarcolemmal Ca2+ pump (PMCA) and the large-conduc-
a family of cell adhesion receptors composed of an a- tance Ca2+-activated potassium channel (BKCa). These
subunit (several types of 140±210 kDa) and a b-subunit caveolae thus assemble the key players in Ca2+ handling and
(several types of 90±130 kDa), which are involved in are, furthermore, in close proximity to parts of the SR.
establishing cell-to-cell and cell-to-extracellular matrix The smooth muscle L-type Ca2+-channel mainly serves to
(ECM) contacts. Integrins are potential force-transduction ®ll and maintain the Ca2+ content of the SR (Fig. 5). As in
proteins because they span the surface membrane and link myocytes, the Ca2+-channel is activated by PKA phos-
the ECM to the underlying actin cytoskeleton in specialized phorylation induced by b-AR stimulation, increasing
focal contact regions. Integrins activate signalling cascades cAMP. PKA is recruited to the membrane for Ca2+-channel
similar to those activated by growth factor receptors (Figs 1 phosphorylation by the PKA-anchoring protein AKAP. At
and 2), but unlike these, integrins possess no intrinsic high concentrations of cAMP, the Ca2+-channel stimulation
tyrosine kinase activity and must therefore signal via by PKA may, however, be attenuated for the following
cytoplasmic kinases (Fig. 5). Such an integrin-linked reasons. PKG is an important mediator of vascular relax-
serine-threonine kinase (ILK) has recently been shown to ation induced by the endothelial derived relaxing factor
phosphorylate the MBS of MLCP, CPI-17, as well as the nitric oxide (NO), which stimulates the cytoplasmic
myosin RLC in a Ca2+-independent manner. Induction of
46
Mechanisms in sympatho-modulation
Table 1 Main adrenergic receptor subtype signalling and functions in nervous, cardiac and vascular tissues. CNS, central nervous system; for signalling
components consult legends to Figures 1±3. Literature references are given in the text
As mentioned above for the integrin-ILK signalling for enzyme systems for sequential phosphorylation and dephos-
phosphorylation of myosin RLC and MLCP, integrin- phorylation steps. (ii) Vascular smooth muscle tone can be
dependent signalling involving a tyrosine phosphorylation achieved by various agonists via GPCR and Gaq-induced
cascade can also activate the L-type Ca2+-channel. This signalling in a Ca2+-independent manner. The degree of
signalling pathway may translate mechanical forces of the vasoconstriction depends primarily on the activity ratio
ECM-linked integrins directly to an increase in Ca2+ entry, between MLCK and MLCP. The term `Ca2+-sensitization'
leading to an increase in vascular tone. (an increase in force without an increase in cytoplasmic
Ca2+) is referred to in the context of inhibition of the MLCP.
(iii) Smooth muscle tone depends on very slow turnover of
the myosin crossbridges with a low degree of phosphoryl-
Hallmarks of smooth muscle versus ation and, consequently, low ATP consumption (an energy-
myocardial regulation saving mechanism). (iv) In large conduit arteries it seems
The following characteristics differentiate smooth muscle that force maintenance depends predominantly on actin
regulation from that of the myocardium. (i) Smooth muscle ®lament regulation. In contrast, in small resistance arteries
contraction and relaxation are slow processes (in the range the a1-AR-mediated signalling via the Rho±ROK pathway,
of seconds to minutes) compared with heart muscle (in the resulting in Ca2+-sensitization of myosin-II, appears to
range of milliseconds). In heart muscle the on±off switch is prevail. (v) Unlike in heart muscle, where b-AR signalling
effected by allosteric conformational changes in the increases total intracellular Ca2+ in proportion to the
contractile protein complex (myosin-II, actin, troponin and inotropic effect, in vascular smooth muscle b-AR signalling
tropomyosin), by fast and reversible binding of Ca2+ leads to relaxation by inhibiting the activation of myosin-II,
to cardiac TnC. Regulation in smooth muscle operates independent of the cellular Ca2+. This last point represents
exclusively via covalent protein modi®cation by reversible the basis for understanding some of the major unwanted side
phosphorylation of myosin RLC and/or actin ®lament effects of b-AR blocker treatment, such as peripheral
components. These processes require the activation of vasoconstriction, increased bronchial resistance and the risk
47
Zaugg and Schaub
48
Mechanisms in sympatho-modulation
relations in the receptor microenvironment (Fig. 1). It was modes follow distinct pathways, which are intimately
demonstrated that apoptotic myocyte cell death is dis- interlinked. On the one hand, the signalling crosstalk entails
sociated from b2-AR and selectively mediated by b1-AR in considerable redundancy, securing cardiac function under
isolated ventricular myocytes and in intact hearts abruptly changing or even adverse conditions. On the other
in vivo.96 98 99 The possible activation of different G- hand, it reveals a ®ne-tuning of regulation that is well suited
proteins by b2-ARs may result in distinct downstream for differentiated pharmacological interventions. What have
signalling pathways. The chronic catecholamine-dependent not been dealt with in this review are the human
positive inotropy of b2-AR is supported by an increased polymorphisms in adrenergic receptors and in their down-
Ca2+ in¯ux via the L-type Ca2+-channel without cardiotoxic stream signalling components that have recently come to
consequences. This is achieved by locally restricted light; these may affect the established adrenergic signalling
signalling to the Ca2+-channel located close by in the in some cases. In conclusion, a detailed understanding of the
membrane, and bypasses the b1-typical effects on PLN and basic adrenergic functions in cardiac and vascular tissues is
the contractile proteins. On the other hand, coupling to Gai/ indispensable for the development of new perioperative
Gbg activates several cytoprotective mechanisms (counter- therapeutic strategies and will foster the testing of novel
acting in part the Gas-mediated routes), such as activation hypotheses in randomized clinical trials.
of ATP-dependent K+-channels in the sarcolemma and in
the inner mitochondrial membrane, mediated by different
PKC isoforms, and activation of the protein kinase B (PKB, Acknowledgements
also called Akt). In the latter case, signalling proceeds via This work was supported by Grants from the Swiss National Science
the PI3K and PI3K-dependent kinase-1 (PDK1) pathway Foundation (grant 3200-063417.00 and grant 3200B0-103980/1), the Swiss
49
Zaugg and Schaub
MM. Desensitization of G-protein-coupled receptors in the Na+-Ca2+-exchanger protein levels and diastolic function of
cardiovascular system. Annu Rev Physiol 1999; 61: 169±92 failing human myocardium. Circulation 1999; 99: 641±8
13 Canaves JM, Taylor SS. Classi®cation and phylogenetic analysis of 33 Hefti MA, Harder BA, Eppenberger HM, Schaub MC. Signaling
the cAMP-dependent protein kinase regulatory subunit family. J pathways in cardiac hypertrophy. J Mol Cell Cardiol 1997; 29:
Mol Evol 2002; 54: 17±29 2873±92
14 Carafoli E. Calcium signaling: a tale for all seasons. Proc Natl Acad 34 Hering S, Berjukow S, Sokolov S, et al. Molecular determinants of
Sci USA 2002; 99: 1115±22 inactivation in voltage-gated Ca2+ channels. J Physiol (London)
15 Cox DH, Aldrich RW. Role of the b1 subunit in large- 2000; 528: 237±49
conductance Ca2+-activated K+ channel gating energetics. 35 Houslay MD, Adams DR. PDE4 cAMP phosphodiesterase:
Mechanisms of enhanced Ca2+ sensitivity. J Gen Physiol 2000; modular enzymes that orchestrate signalling cross-talk,
116: 411±32 desensitization and compartmentalization. Biochem J 2003; 370:
16 da Silva CP, Guse AH. Intracellular Ca2+ release mechanisms: 1±18
multiple pathways having multiple functions within the same cell 36 Ingber DE. Mechanical signaling and the cellular response to
type? Biochim Biophys Acta 2000; 1498: 122±33 extracellular matrix in angiogenesis and cardiovascular
17 Eckert RE, Karsten AJ, Utz J, Ziegler M. Regulation of renal physiology. Circ Res 2002; 91: 877±87
artery smooth muscle tone by a1-adrenoceptors: role of 37 Johnson GL, Lapadat R. Mitogen-activated protein kinase
voltage-gated calcium channels and intracellular calcium stores. pathways mediated by ERK, JNK, and p38 protein kinases.
Urol Res 2000; 28: 122±7 Science 2002; 298: 1911±2
18 Ertel SI, Ertel EA. Low-voltage-activated T-type Ca2+ channels. 38 Kamm KE, Stull JT. Dedicated myosin light chain kinases with
Trends Pharmacol Sci 1997; 18: 37±42 diverse cellular functions. J Biol Chem 2001; 276: 4527±30
19 Esler M, Lambert G, Brunner-La Rocca HP, Vaddadi G, Kaye D. 39 Kamp TJ, Hell JW. Regulation of cardiac L-type calcium channels
Sympathetic nerve activity and neurotransmitter release in by protein kinase A and protein kinase C. Circ Res 2002; 87:
1095±102
50
Mechanisms in sympatho-modulation
54 Michelotti GA, Price DT, Schwinn DA. Alpha1-adrenergic spanning receptors and heart function. Nature 2002; 414: 206±
receptor regulation: basic science and clinical implications. 12
Pharmacol Ther 2000; 88: 281±309 77 Saimi Y, Kung C. Calmodulin as an ion channel subunit. Annu Rev
55 Molkentin JD, Dorn GW. Cytoplasmic signaling pathways that Physiol 2002; 64: 289±311
regulate cardiac hypertrophy. Annu Rev Physiol 2001; 63: 391±426 78 Salahpour A, Angers S, Bouvier M. Functional signi®cance of
56 Moosmang S, Stieber J, Zong X, Biel M, Hofmann F, Ludwig A. oligomerization of G-protein-coupled receptors. Trends
Cellular expression and functional characterization of four Endocrinol Metab 2000; 11: 163±8
hyperpolarization-activated pacemaker channels in cardiac and 79 Schaub MC, Hefti MA, Zuellig RA, Morano I. Modulation of
neuronal tissues. Eur J Biochem 2001; 268: 1646±52 contractility in human cardiac hypertrophy by myosin essential
57 Morano I. Tuning smooth muscle contraction by molecular light chain isoforms. Cardiovasc Res 1998; 37: 381±404
motors. J Mol Med 2003; 81: 481±7 80 Scholz J, Tonner PH. a2-Adrenoceptor agonists in anaesthesia: a
58 Murphy RA. What is special about smooth muscle? The new paradigm. Curr Opin Anesthesiol 2000; 13: 437±42
signi®cance of covalent crossbridge regulation. FASEB J 1994; 8: 81 Schubert R, Nelson MT. Protein kinases: tuners of the BKCa
311±18 channel in smooth muscle. Trends Pharmacol Sci 2001; 22: 505±12
59 Nakayama S, Kawasaki H, Kretsinger R. Evolution of EF-hand 82 Schulze DH, Muqhal M, Lederer WJ, Ruknudin AM. Sodium/
proteins. In: Carafoli E, Krebs J, eds. Calcium Homeostasis. calcium exchanger (NCX1) macromolecular complex. J Biol
Springer, 2000; 29±58 Chem 2003; 278: 28849±55
60 Neves S, Ram PT, Iyengar R. G-protein pathways. Science 2002; 83 Shakur Y, Fong M, Hensley J, et al. Comparison of the effects of
296: 1636±9 Cilostazol and milrinone on cAMP-PDE activity, intracellular
61 Newton AC. Regulation of the ABC kinases by phosphorylation: cAMP and calcium in the heart. Cardiovasc Drug Ther 2002; 16:
protein kinase-C as a paradigm. Biochem J 2003; 370: 361±71 417±27
62 Nicoll DA, Ottolia M, Lu L, Lu Y, Philipson KD. A new 84 Shin HM, Je HD, Gallant C, et al. Differential association and
51
Zaugg and Schaub
receptor regulates its coupling to Gs and Gi. J Biol Chem 2002; 99 Zaugg M, Schaub MC. Signaling and cellular mechanisms in
277: 31249±56 cardiac protection by ischemic and pharmacological
98 Zaugg M, Schaub MC, Pasch T, Spahn DR. Modulation of b- preconditioning. J Muscle Res Cell Motil 2003; 24: 219±49
adrenergic receptor subtype activities in perioperative medicine: 100 Zylinska L, Kawecka I, Lachowicz L, Szemraj J. The isoform- and
mechanisms and sites of action. Br J Anaesth 2002; 88: location-dependence of the functioning of the plasma membrane
101±23 calcium pump. Cell Mol Biol Lett 2002; 7: 1037±45
52